These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32519001)

  • 21. The implication of vitamin D and autoimmunity: a comprehensive review.
    Yang CY; Leung PS; Adamopoulos IE; Gershwin ME
    Clin Rev Allergy Immunol; 2013 Oct; 45(2):217-26. PubMed ID: 23359064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The link between calcitriol and anticancer immunotherapy: vitamin D as the possible balance between inflammation and autoimmunity in the immune-checkpoint blockade.
    Bersanelli M; Leonetti A; Buti S
    Immunotherapy; 2017 Nov; 9(14):1127-1131. PubMed ID: 29067883
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors.
    König D; Läubli H
    Pharmacology; 2021; 106(3-4):123-136. PubMed ID: 32721966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic use of vitamin D and its analogues in autoimmunity.
    Fletcher JM; Basdeo SA; Allen AC; Dunne PJ
    Recent Pat Inflamm Allergy Drug Discov; 2012 Jan; 6(1):22-34. PubMed ID: 22122009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
    Watad A; Neumann SG; Soriano A; Amital H; Shoenfeld Y
    Isr Med Assoc J; 2016; 18(3-4):177-82. PubMed ID: 27228639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update.
    Kähler KC; Hassel JC; Heinzerling L; Loquai C; Thoms KM; Ugurel S; Zimmer L; Gutzmer R;
    J Dtsch Dermatol Ges; 2020 Jun; 18(6):582-609. PubMed ID: 32489011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D's Effect on Immune Function.
    Martens PJ; Gysemans C; Verstuyf A; Mathieu AC
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32353972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis, autoimmunity, and vitamin D.
    Shapira Y; Agmon-Levin N; Shoenfeld Y
    Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):169-77. PubMed ID: 19543859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D and autoimmune rheumatic disease.
    García-Carrasco M; Romero JL
    Reumatol Clin; 2015; 11(6):333-4. PubMed ID: 26679100
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events.
    Zhuang J; Du J; Guo X; Zhou J; Duan L; Qiu W; Si X; Zhang L; Li Y; Liu X; Wang H; Zhou D; Zhang L
    Thorac Cancer; 2020 Mar; 11(3):799-804. PubMed ID: 32017466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D and autoimmune thyroid diseases: facts and unresolved questions.
    Bizzaro G; Shoenfeld Y
    Immunol Res; 2015 Feb; 61(1-2):46-52. PubMed ID: 25407646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D and immune function.
    Prietl B; Treiber G; Pieber TR; Amrein K
    Nutrients; 2013 Jul; 5(7):2502-21. PubMed ID: 23857223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
    Czaja AJ; Montano-Loza AJ
    Dig Dis Sci; 2019 Feb; 64(2):324-344. PubMed ID: 30370494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of immune checkpoint inhibitor-related dermatologic adverse events.
    Si X; He C; Zhang L; Liu X; Li Y; Wang H; Guo X; Zhou J; Duan L; Wang M; Zhang L
    Thorac Cancer; 2020 Feb; 11(2):488-492. PubMed ID: 31814310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complex role of vitamin D in autoimmune diseases.
    Szodoray P; Nakken B; Gaal J; Jonsson R; Szegedi A; Zold E; Szegedi G; Brun JG; Gesztelyi R; Zeher M; Bodolay E
    Scand J Immunol; 2008 Sep; 68(3):261-9. PubMed ID: 18510590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Predictive Biomarkers of Immune-related Adverse Events Induced by Checkpoint Inhibitors in Malignancies].
    Tang H; Guan M; Sun Z; Bai CM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):825-830. PubMed ID: 33423733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma?
    Banks LB; Sullivan RJ
    Am J Clin Dermatol; 2020 Jun; 21(3):313-321. PubMed ID: 32026236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.
    Cantorna MT; Mahon BD
    Exp Biol Med (Maywood); 2004 Dec; 229(11):1136-42. PubMed ID: 15564440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Part 2: Imaging findings of uncommon but important immune checkpoint inhibitor-related adverse effects.
    Noë G; Cardin A; Lasocki A
    J Med Imaging Radiat Oncol; 2022 Jun; 66(4):502-507. PubMed ID: 35233953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune Endocrinopathies: An Emerging Complication of Immune Checkpoint Inhibitors.
    Quandt Z; Young A; Perdigoto AL; Herold KC; Anderson MS
    Annu Rev Med; 2021 Jan; 72():313-330. PubMed ID: 32886542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.